Cargando…
Single-cell transcriptomic atlas-guided development of CAR-T cells for the treatment of acute myeloid leukemia
Chimeric-antigen receptor (CAR) T cells have emerged as a powerful treatment option for patients with B cell malignancies but have yet to achieve success in treating acute myeloid leukemia (AML) due to a lack of safe targets. Here, we leveraged an atlas of publicly available RNA sequencing data of o...
Ejemplares similares
-
Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy
por: Lorenzini, Theo, et al.
Publicado: (2023) -
Impact of the selective A2(A)R and A2(B)R dual antagonist AB928/etrumadenant on CAR T cell function
por: Seifert, Matthias, et al.
Publicado: (2022) -
A modular and controllable T cell therapy platform for acute myeloid leukemia
por: Benmebarek, Mohamed-Reda, et al.
Publicado: (2021) -
Programmable multispecific DNA-origami-based T-cell engagers
por: Wagenbauer, Klaus F., et al.
Publicado: (2023) -
CAR T cell therapy in solid tumors: a short review
por: Umut, Öykü, et al.
Publicado: (2021)